InsidersTradesSigma
Track the PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 share price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 has recorded 0 reports. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA is a company operating in the health and pharmaceutical sector, specializing in the development of nutraceutical products. The interim report as of September 30, 2023 provides insights into its financial and operational performance.